Elanco director granted 600 Deferred Stock Units

Anand Kapila K reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Anand Kapila K reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc director K. Anand received an automatic grant of 600.7104 Deferred Stock Units as part of her director compensation. These units reflect cash retainer fees she chose to defer under the Company’s Directors' Deferral Plan, using a grant-date Elanco common stock price of $23.93.

Each Deferred Stock Unit is economically equivalent to one share of Elanco common stock and will be settled in stock when she separates from the Board. Following this award, she holds a total of 9,495.4518 Deferred Stock Units directly.

Insider Trade Summary

Grant/Award: 600.7104 shares

Grant/Award 1 txn

Insider Anand Kapila K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	600.7104	$23.93	$14K

Holdings After Transaction: Deferred Stock Units — 9,495.4518 contracts (Direct)

Footnotes (3)

1. F1. Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
2. F2. The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
3. F3. The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.93 on March 31, 2026.

Key Figures

Deferred Stock Units granted: 600.7104 units Grant-date share price: $23.93 per share Deferred Stock Units after transaction: 9,495.4518 units +2 more

5 metrics

Deferred Stock Units granted 600.7104 units Director compensation deferral on March 31, 2026

Grant-date share price $23.93 per share Elanco common stock closing price on March 31, 2026

Deferred Stock Units after transaction 9,495.4518 units Total Deferred Stock Units held directly by director after award

Conversion or exercise price $0.00 Deferred Stock Units issued with zero exercise price

Underlying security 600.7104 common shares equivalent Each Deferred Stock Unit equals one share of common stock

Key Terms

Deferred Stock Units, Directors' Deferral Plan, Elanco Deferred Stock Account, separation of service

4 terms

Deferred Stock Units financial

"Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Directors' Deferral Plan financial

"Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan."

Elanco Deferred Stock Account financial

"such deferred fees were credited to the Elanco Deferred Stock Account under the Plan."

separation of service financial

"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elanco (ELAN) director K. Anand report in this Form 4?

Elanco director K. Anand reported receiving 600.7104 Deferred Stock Units as director compensation. The units result from deferring cash retainer fees under the company’s Directors' Deferral Plan and are tied to Elanco’s $23.93 share price on March 31, 2026.

How many Deferred Stock Units does the Elanco (ELAN) director hold after this transaction?

After this transaction, director K. Anand holds 9,495.4518 Deferred Stock Units. These units represent deferred director compensation and are economically equivalent to Elanco common stock, to be settled in shares when she leaves the company’s Board of Directors.

How were the 600.7104 Deferred Stock Units for Elanco (ELAN) calculated?

The 600.7104 Deferred Stock Units were calculated by dividing the deferred cash compensation by Elanco’s closing common stock price. The price used was $23.93 on March 31, 2026, as specified in the company’s Directors' Deferral Plan documentation.

When will the Elanco (ELAN) Deferred Stock Units be settled into shares?

The Deferred Stock Units will be settled in Elanco common stock when director K. Anand separates from service on the Board. Settlement occurs under the terms of the Directors' Deferral Plan, converting accumulated units into actual shares at that time.

Are Elanco (ELAN) Deferred Stock Units the same as common shares now?

Deferred Stock Units are not current shares but are economically equivalent to one Elanco common share each. They represent deferred compensation that will convert into actual common stock upon the director’s separation from the Board under the company’s deferral plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:02 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anand Kapila K

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units(1)(2)	(3)	03/31/2026		A		600.7104		(1)	(1)	Common Stock	600.7104	$23.93(2)(3)	9,495.4518	D

Explanation of Responses:

1. Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

2. The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

3. The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.93 on March 31, 2026.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Kapila K. Anand	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)